Goodman Advisory Group’s Boston Scientific BSX Stock Holding History

Goodman Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.2K	Buy	+600	New	+$27.8K	0.01%	118

Other funds holding BSX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Goodman Advisory Group's BSX Position: Q3 2026 in Review

Goodman Advisory Group opened a new position in Boston Scientific (BSX) in Q3 2026: 600 shares worth $26.2K. The stake represents 0.01% of the portfolio and ranks #118 among its holdings.

1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Goodman Advisory Group held 600 shares of Boston Scientific worth $26.2K as of Q3 2026.
Boston Scientific was a new Goodman Advisory Group position in Q3 2026.
Boston Scientific made up 0.01% of Goodman Advisory Group's portfolio in Q3 2026, its #118 holding.
1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Goodman Advisory Group's 13F filing for Q3 2026, filed 2 Nov 2026.